LISA RINK: Open Payments
NPI 1437101623 · HADDON HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 29 payments from 11 companies in 2025. Trend: 2023 $366 · 2024 $520 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $104 |
| Amgen Inc. | 6 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Indivior Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $41 |
| PFIZER INC. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Almatica Pharma LLC | 1 | $16 |
Products named: REXULTI, OTEZLA, XIFAXAN, SUBLOCADE, FARXIGA, Cologuard Collection Kit, PAXLOVID, XYOSTED.
Industry payments across NJ — which companies pay providers there.
